These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 9726676)

  • 1. Betahistine mesylate reduces the damage of blue light exposure in Drosophila model.
    Li X; Zhao Z; He J; Shen J
    J Photochem Photobiol B; 2024 Oct; 259():113009. PubMed ID: 39141982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histaminergic System and Vestibular Function in Normal and Pathological Conditions.
    Tighilet B; Trico J; Marouane E; Zwergal A; Chabbert C
    Curr Neuropharmacol; 2024; 22(11):1826-1845. PubMed ID: 38504566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine and Its Receptors in the Mammalian Inner Ear: A Scoping Review.
    Kong L; Domarecka E; Szczepek AJ
    Brain Sci; 2023 Jul; 13(7):. PubMed ID: 37509031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic pharmacological interventions for Ménière's disease.
    Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological Measurements of Peripheral Vestibular Function-A Review of Electrovestibulography.
    Brown DJ; Pastras CJ; Curthoys IS
    Front Syst Neurosci; 2017; 11():34. PubMed ID: 28620284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
    Nauta JJ
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):887-97. PubMed ID: 23778722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.
    Monzani D; Barillari MR; Alicandri Ciufelli M; Aggazzotti Cavazza E; Neri V; Presutti L; Genovese E
    Acta Otorhinolaryngol Ital; 2012 Dec; 32(6):393-403. PubMed ID: 23349559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability.
    Desmadryl G; Gaboyard-Niay S; Brugeaud A; Travo C; Broussy A; Saleur A; Dyhrfjeld-Johnsen J; Wersinger E; Chabbert C
    Br J Pharmacol; 2012 Oct; 167(4):905-16. PubMed ID: 22624822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacology of vestibular system disorders.
    Soto E; Vega R
    Curr Neuropharmacol; 2010 Mar; 8(1):26-40. PubMed ID: 20808544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betahistine in the treatment of Ménière's disease.
    Lacour M; van de Heyning PH; Novotny M; Tighilet B
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):429-40. PubMed ID: 19300572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of vertigo.
    Hain TC; Uddin M
    CNS Drugs; 2003; 17(2):85-100. PubMed ID: 12521357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
    Lacour M; Sterkers O
    CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betahistine reduces the resting firing rate of vestibular receptors in the frog.
    Valli P
    Acta Otolaryngol Suppl; 2000; 544():8-10. PubMed ID: 10904794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of betahistine and of its metabolites on vestibular sensory organs.
    Botta L; Mira E; Valli S; Zucca G; Benvenuti C; Fossati A; Soto E; Guth P; Valli P
    Acta Otorhinolaryngol Ital; 2001 Jun; 21(3 Suppl 66):24-30. PubMed ID: 11677836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of betahistine metabolites on frog ampullar receptors.
    Botta L; Mira E; Valli S; Zucca G; Perin P; Benvenuti C; Fossati A; Valli P
    Acta Otolaryngol; 2000 Jan; 120(1):25-7. PubMed ID: 10779181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiopathology of H3-receptors and pharmacology of betahistine.
    Van Cauwenberge PB; De Moor SE
    Acta Otolaryngol Suppl; 1997; 526():43-6. PubMed ID: 9107355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification.
    Lacour M
    J Vestib Res; 2013; 23(3):139-51. PubMed ID: 24177346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of betahistine on vestibular receptors of the frog.
    Botta L; Mira E; Valli S; Perin P; Zucca G; Valli P
    Acta Otolaryngol; 1998 Jul; 118(4):519-23. PubMed ID: 9726676
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.